Literature DB >> 24120462

1H-NMR metabolic profiling of cerebrospinal fluid in patients with complex regional pain syndrome-related dystonia.

Axel Meissner1, Anton A van der Plas, Nick T van Dasselaar, André M Deelder, Jacobus J van Hilten, Oleg A Mayboroda.   

Abstract

In complex regional pain syndrome (CRPS)-related dystonia, compelling evidence points to the involvement of the central nervous system, but the underpinning pathobiology is still unclear. Thus, to enable a hypothesis-free, unbiased view of the problem and to obtain new insight into the pathobiology of dystonia in CRPS, we applied an exploratory metabolomics analysis of cerebrospinal fluid (CSF) of patients with CRPS-related dystonia. (1)H-NMR spectroscopy in combination with multivariate modeling were used to investigate metabolic profiles of a total of 105 CSF samples collected from patients with CRPS-related dystonia and controls. We found a significantly different metabolic profile of CSF in CRPS patients compared to controls. The differences were already reflected in the first two principal components of the principal component analysis model, which is an indication that the variance associated with CRPS is stronger than variance caused by such classical confounders as gender, age, or individual differences. A supervised analysis generated a strong model pinpointing the most important metabolites contributed to the metabolic signature of patients with CRPS-related dystonia. From the set of identified discriminators, the most relevant metabolites were 2-keto-isovalerate, glucose, glutamine, and lactate, which all showed increased concentrations, and urea, which showed decreased concentration in CRPS subjects. Our findings point at a catabolic state in chronic CRPS patients with dystonia that is likely associated with inflammation.
Copyright © 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CSF analysis; Complex regional pain syndromes; Metabolomics; NMR

Mesh:

Substances:

Year:  2013        PMID: 24120462     DOI: 10.1016/j.pain.2013.10.005

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  5 in total

1.  The Metabolomics of Chronic Pain Conditions: A Systematic Review.

Authors:  Edwin N Aroke; Keesha L Powell-Roach
Journal:  Biol Res Nurs       Date:  2020-07-15       Impact factor: 2.522

2.  The related mechanism of complete Freund's adjuvant-induced chronic inflammation pain based on metabolomics analysis.

Authors:  Weibo Zhang; Jie Lyu; Juxiang Xu; Piao Zhang; Shuxia Zhang; Yeru Chen; Yongjie Wang; Gang Chen
Journal:  Biomed Chromatogr       Date:  2021-01-28       Impact factor: 1.902

Review 3.  Metabolomics in Central Sensitivity Syndromes.

Authors:  Joseph S Miller; Luis Rodriguez-Saona; Kevin V Hackshaw
Journal:  Metabolites       Date:  2020-04-24

Review 4.  Lysophosphatidylcholine: Potential Target for the Treatment of Chronic Pain.

Authors:  Jinxuan Ren; Jiaqi Lin; Lina Yu; Min Yan
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

5.  Can Urine Metabolomics Be Helpful in Differentiating Neuropathic and Nociceptive Pain? A Proof-of-Concept Study.

Authors:  Gabriele Finco; Emanuela Locci; Paolo Mura; Roberta Massa; Antonio Noto; Mario Musu; Giovanni Landoni; Ernesto d'Aloja; Fabio De-Giorgio; Paola Scano; Maurizio Evangelista
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.